A Prospective Study to Evaluate the ConforMIS iTotal® (PS) Knee Replacement System
Status: | Recruiting |
---|---|
Conditions: | Arthritis, Osteoarthritis (OA) |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/4/2018 |
Start Date: | May 1, 2017 |
End Date: | May 2028 |
Contact: | Marc Quartulli |
Email: | Marc.Quartulli@conformis.com |
Phone: | 781-345-9191 |
This is a prospective clinical study designed to observe the long-term clinical outcomes of
total knee arthroplasty using a patient-specific, posterior stabilized implant in patients
with osteoarthritis.
total knee arthroplasty using a patient-specific, posterior stabilized implant in patients
with osteoarthritis.
The study is prospective. Subjects will be implanted with an iTotal® PS Knee Replacement
System. The study will include a minimum of 100 subjects across up to 10 sites. The patients
enrolled in this study may represent the first cases of the iTotal PS KRS implanted at a
particular site; data collected for the first 15 patients at each site will be analyzed
separately from the rest of the enrolled population. This will provide visibility towards
determining if there exists a learning curve in the implantation process of the iTotal PS
KRS. The study sites will be located in the United States.
System. The study will include a minimum of 100 subjects across up to 10 sites. The patients
enrolled in this study may represent the first cases of the iTotal PS KRS implanted at a
particular site; data collected for the first 15 patients at each site will be analyzed
separately from the rest of the enrolled population. This will provide visibility towards
determining if there exists a learning curve in the implantation process of the iTotal PS
KRS. The study sites will be located in the United States.
Inclusion Criteria:
- Clinical condition included in the approved Indications For Use for the iTotal® PS
- Osteoarthritis, as confirmed by the investigator's assessment of disease status at
screening visit that warrants a TKR procedure. Disease status is assessed by Clinical
and Radiographic assessment.
- Willingness to participate in the clinical study, to give informed consent, and to
attend all follow-up visits
- > 18 years of age
Exclusion Criteria:
- Simultaneous bilateral procedure required
- BMI > 40
- Active malignancy (defined as a history of any invasive malignancy - except non-
melanoma skin cancer), unless patient has been treated with curative intent and there
have been no clinical signs or symptoms of the malignancy for at least 5 years
- Poorly controlled diabetes
- Neuromuscular conditions which prevent patient from participating in study activities
- Active local or systemic infection
- Immunocompromised
- Fibromyalgia or other general body pain related condition
- Rheumatoid arthritis or other forms of inflammatory joint disease
- Loss of bone or musculature, osteonecrosis, neuromuscular or vascular compromise in
the area of the joint to be operated on, to an extent that the procedure is
unjustified
- Diagnosed with or receiving treatment for Osteoporosis
- Other physical disability affecting the hips, spine, or contralateral knee
- Severe instability due to advanced loss of osteochondral structure
- Prior arthroplasty of the affected knee, including High Tibial Osteotomy (HTO)
- Unwilling or unable to comply with study requirements
- Participation in another clinical study which would confound results
- Allergy to any of the implant materials
We found this trial at
4
sites
Morrisville, Vermont 05661
Principal Investigator: Bryan Huber, MD
Phone: 802-888-8405
Click here to add this to my saved trials
Austin, Texas 78751
Principal Investigator: Eric M Heinrich, MD
Phone: 512-583-0217
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials